Research findings indicate that an endocrinologist's treatment of patients hospitalized with diabetic ketoacidosis is more cost-effective than general physicians' treatment of those patients due to greater experience in specialized treatment.
Douglas E. Paull, MD, MS and Paul N. Uhlig, MD, MPA
Risk managers can help patient-subjects and clinician-researchers make informed novel device implantation decisions in the absence of preclinical trial data.
AMA J Ethics. 2020; 22(11):E911-918. doi:
10.1001/amajethics.2020.911.